BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10367131)

  • 1. [Genetic analysis of changes in sizes of telomeres and anti-oncogenes p53 and Rb in children with pre-B acute lymphoblastic leukemia].
    Klots IN; Indzhiia LV; Chepnian ER; Lapin BA
    Biull Eksp Biol Med; 1999 Apr; 127(4):439-41. PubMed ID: 10367131
    [No Abstract]   [Full Text] [Related]  

  • 2. Aberrant expression of tumor suppressor genes and their association with chimeric oncogenes in pediatric acute lymphoblastic leukemia.
    Kustanovich AM; Savitskaja TV; Bydanov OI; Belevtsev MV; Potapnev MP
    Leuk Res; 2005 Nov; 29(11):1271-6. PubMed ID: 15878620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymidylate synthase gene polymorphism and its association with relapse in childhood B-cell precursor acute lymphoblastic leukemia.
    Lauten M; Asgedom G; Welte K; Schrappe M; Stanulla M
    Haematologica; 2003 Mar; 88(3):353-4. PubMed ID: 12651279
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential microRNA expression in childhood B-cell precursor acute lymphoblastic leukemia.
    Ju X; Li D; Shi Q; Hou H; Sun N; Shen B
    Pediatr Hematol Oncol; 2009 Jan; 26(1):1-10. PubMed ID: 19206004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translocation (1;13)(p34;q32) in childhood pre-B-cell acute lymphoblastic leukemia.
    Wan TS; Ma SK; Ching LM; Chan LC; Chan GC; Ha SY
    Cancer Genet Cytogenet; 2000 Aug; 121(1):107-8. PubMed ID: 10991621
    [No Abstract]   [Full Text] [Related]  

  • 6. Mixed lineage leukemia-rearranged childhood pro-B and CD10-negative pre-B acute lymphoblastic leukemia constitute a distinct clinical entity.
    Attarbaschi A; Mann G; König M; Steiner M; Strehl S; Schreiberhuber A; Schneider B; Meyer C; Marschalek R; Borkhardt A; Pickl WF; Lion T; Gadner H; Haas OA; Dworzak MN
    Clin Cancer Res; 2006 May; 12(10):2988-94. PubMed ID: 16707593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of glutathione S-transferase gene deletion on early relapse in childhood B-precursor acute lymphoblastic leukemia.
    Takanashi M; Morimoto A; Yagi T; Kuriyama K; Kano G; Imamura T; Hibi S; Todo S; Imashuku S
    Haematologica; 2003 Nov; 88(11):1238-44. PubMed ID: 14607752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Karyotype refinement by multicolor fluorescence in situ hybridization analysis in 18 patients with acute lymphoblastic leukemia.
    Calabrese G; Taraborelli T; Fantasia D; Guanciali Franchi P; Spadano A; Palka G
    Haematologica; 2002 Aug; 87(8):888-9. PubMed ID: 12161369
    [No Abstract]   [Full Text] [Related]  

  • 10. CDKN2 deletions have no prognostic value in childhood precursor-B acute lymphoblastic leukaemia.
    van Zutven LJ; van Drunen E; de Bont JM; Wattel MM; Den Boer ML; Pieters R; Hagemeijer A; Slater RM; Beverloo HB
    Leukemia; 2005 Jul; 19(7):1281-4. PubMed ID: 15843818
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of balanced rearrangements of chromosome 6 in acute leukemia: clustered breakpoints in q22-q23 and possible involvement of c-MYB in a new recurrent translocation, t(6;7)(q23;q32 through 36).
    Sinclair P; Harrison CJ; Jarosová M; Foroni L
    Haematologica; 2005 May; 90(5):602-11. PubMed ID: 15921375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic significance of CDKN2A, CDKN2B and MTAP inactivation in B-lineage acute lymphoblastic leukemia of childhood. Results of the EORTC studies 58881 and 58951.
    Mirebeau D; Acquaviva C; Suciu S; Bertin R; Dastugue N; Robert A; Boutard P; Méchinaud F; Plouvier E; Otten J; Vilmer E; Cavé H;
    Haematologica; 2006 Jul; 91(7):881-5. PubMed ID: 16818274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of CDKN2A, CDKN2B and MTAP in childhood B-lineage acute lymphobastic leukemia.
    Beverloo HB
    Haematologica; 2006 Jul; 91(7):865B. PubMed ID: 16818264
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic abnormalities associated with the t(12;21) and their impact in the outcome of 56 patients with B-precursor acute lymphoblastic leukemia.
    Alvarez Y; Coll MD; Ortega JJ; Bastida P; Dastugue N; Robert A; Cervera J; Verdeguer A; Tasso M; Aventín A; Guitart M; Caballín MR
    Cancer Genet Cytogenet; 2005 Oct; 162(1):21-9. PubMed ID: 16157196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Near-haploidy in myeloid antigen positive childhood acute lymphoblastic leukemia.
    Mukherjee S; Das Gupta A; Khodaiji S; Agarwal MB
    Am J Hematol; 2001 Aug; 67(4):276-7. PubMed ID: 11443648
    [No Abstract]   [Full Text] [Related]  

  • 16. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.
    Medeiros BC
    N Engl J Med; 2009 Apr; 360(17):1787; author reply 1787-8. PubMed ID: 19387020
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute lymphoblastic leukemia.
    Onciu M
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):655-74. PubMed ID: 19577163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinction of acute lymphoblastic leukemia from acute myeloid leukemia through microarray-based DNA methylation analysis.
    Scholz C; Nimmrich I; Burger M; Becker E; Dörken B; Ludwig WD; Maier S
    Ann Hematol; 2005 Apr; 84(4):236-44. PubMed ID: 15538567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of multidrug resistance gene (MDR1) at relapse in a child with acute lymphoblastic leukemia.
    Kourti M; Vavatsi N; Gombakis N; Tzimagiorgis G; Sidi V; Koliouskas D; Athanassiadou F
    Pediatr Hematol Oncol; 2006 Sep; 23(6):489-94. PubMed ID: 16849280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Harder L; Wang H; Wartenberg M; Hofmann WK; Wernet P; Siebert R; Müschen M
    J Exp Med; 2004 Mar; 199(5):673-85. PubMed ID: 14993251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.